Total Payments
$3,201
2024 Payments
$980.35
Companies
40
Transactions
189
Medicare Patients
437
Medicare Billing
$30,451
Payment Breakdown by Category
Food & Beverage$3,201 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,201 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $567.02 | 32 | $0 (2024) |
| Novo Nordisk Inc | $325.66 | 19 | $0 (2024) |
| ABBVIE INC. | $312.61 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $262.43 | 17 | $0 (2024) |
| PFIZER INC. | $247.59 | 15 | $0 (2024) |
| Lilly USA, LLC | $184.91 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $170.49 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $127.03 | 6 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $102.93 | 6 | $0 (2022) |
| Amgen Inc. | $78.34 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.35 | 52 | AstraZeneca Pharmaceuticals LP ($328.60) |
| 2023 | $778.37 | 43 | ABBVIE INC. ($133.99) |
| 2022 | $710.12 | 44 | Novo Nordisk Inc ($126.07) |
| 2021 | $731.66 | 50 | AstraZeneca Pharmaceuticals LP ($114.86) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: PAIN | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 58 | 58 | $10,920 | $3,234 |
| 2022 | 4 | 85 | 85 | $17,185 | $6,373 |
| 2021 | 7 | 182 | 182 | $34,565 | $12,628 |
| 2020 | 4 | 112 | 112 | $25,771 | $8,216 |
Total Patients
437
Total Services
437
Medicare Billing
$30,451
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $6,380 | $1,541 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,740 | $1,277 | 34.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 12 | $800.00 | $415.44 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,665 | $1,751 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $5,280 | $1,681 | 31.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 31 | 31 | $3,720 | $1,571 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,520 | $1,370 | 38.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 42 | 42 | $9,240 | $3,690 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 43 | $9,460 | $2,933 | 31.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,330 | $2,413 | 38.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 34 | 34 | $4,080 | $1,745 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $3,840 | $1,039 | 27.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2021 | 15 | 15 | $1,275 | $769.65 | 60.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 17 | 17 | $340.00 | $38.25 | 11.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 44 | 44 | $9,680 | $3,394 | 35.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 35 | 35 | $11,661 | $3,068 | 26.3% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2020 | 20 | 20 | $1,570 | $1,026 | 65.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $2,860 | $727.82 | 25.4% |
About Angela Maceri
Angela Maceri is a Family healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679010821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Maceri has received a total of $3,201 in payments from pharmaceutical and medical device companies, with $980.35 received in 2024. These payments were reported across 189 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,201).
As a Medicare-enrolled provider, Maceri has provided services to 437 Medicare beneficiaries, totaling 437 services with total Medicare billing of $30,451. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Troy, MI
- Active Since 01/26/2017
- Last Updated 01/31/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679010821
Products in Payments
- FARXIGA (Drug) $243.14
- NURTEC ODT (Drug) $231.49
- BREZTRI (Drug) $225.09
- VRAYLAR (Drug) $135.23
- Rybelsus (Drug) $129.94
- Ozempic (Drug) $116.20
- TRELEGY ELLIPTA (Drug) $113.16
- TRULICITY (Drug) $113.00
- UBRELVY (Drug) $98.34
- JARDIANCE (Drug) $80.75
- Azstarys (Drug) $75.17
- MOUNJARO (Drug) $71.91
- AIRSUPRA (Drug) $67.69
- SPRAVATO (Drug) $66.68
- XARELTO (Drug) $60.35
- ELIQUIS (Drug) $58.93
- MYRBETRIQ (Drug) $58.82
- STIOLTO RESPIMAT (Drug) $57.79
- Cologuard Collection Kit (Device) $52.25
- ENTRESTO (Drug) $52.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Troy
Mrs. Daniela Maxim, Fnp-Bc, FNP-BC
Family — Payments: $97,995
Family $97,995
Stephanie Reese
Family — Payments: $15,477
Family $15,477
Deidra Knauth, Fnp, FNP
Family — Payments: $13,328
Family $13,328
Mrs. Pamela Jones, R.n., N.p, R.N., N.P
Family — Payments: $11,382
Family $11,382
Mackenzie Difiore, Np, NP
Family — Payments: $9,161
Family $9,161
Marsha Smith
Family — Payments: $6,971
Family $6,971